Hyperkalemia is a potentially life-threatening condition, which may occur in many clinical settings. Heparin-induced hyperkalemia is less well-recognized than other side effects of heparin therapy. Even lesser known is heparin abuse amongst drug addicts. We report a case of fatal hyperkalemia related to long-term heparin abuse, which was refractory to anti-hyperkalemia therapy including hemodialysis. The objective is to alert the clinicians to possible abuse of heparin in drug addicts, which can be a cause for refractory hyperkalemia. We also briefly review the available literature on heparin-induced hyperkalemia.
Thomas CM, Thomas J, Smeeton F, Leatherdale BA. Heparin-induced hyperkalemia. Diabetes Res Clin Pract 2008;80:e7-8.
Lehnhardt A, Kemper MJ. Pathogenesis, diagnosis and management of hyperkalemia. Pediatr Nephrol 2011;26:377-84.
Edes TE, Sunderrajan EV. Heparin-induced hyperkalemia. Arch Intern Med 1985;145:1070-2.
Maqbool Z, Billett HH. Unwitting heparin abuse in a drug addict. Ann Intern Med 1982;96:790-1.
Park SE, Kim DY, Park ES. Hyperkalemia in a patient with rhabdomyolysis and compartment syndrome: A case report. Korean J Anesthesiol 2010;59:S37-40.
Lindblad B. Protamine sulphate: a review of its effects: hypersensitivity and toxicity. Eur J Vasc Surg 1989;3:195-201.
Busch EH, Ventura HO, Lavie CJ. Heparin-induced hyperkalemia. South Med J 1987;80:1450-1.
Donzelot E, Kaufmann H. Heparin in the treatment of rheumatic fever and of certain exsudative diseases. Arch Mal Coeur Vaiss 1950;43:229-40.
Veyrat R, Manning EL, Fabre J, Muller AF. Measurement of aldosterone secretion during the administration of a semi-synthetic adrenostatic agent, heparinoid RO I-8307. Rev Fr Etud Clin Biol 1963;8:667-73.
Gheno G, Savarino C, Vellar S, Cinetto L. Heparin-induced life-threatening hyperkalemia. Ann Ital Med Int 2002;17:51-3.
Aull L, Chao H, Coy K. Heparin-induced hyperkalemia. DICP 1990;24:244-6.
Sherman DS, Kass CL, Fish DN. Fludrocortisone for the treatment of heparin-induced hyperkalemia. Ann Pharmacother 2000;34:606-10.
Kim DM, Chung JH, Yoon SH, Kim HL. Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis. Nephrol Dial Transplant 2007;22:3273-6.
Dreyling KW, Wanner C, Schollmeyer P. Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus. Clin Nephrol 1990;33:179-83.
Sebastian A, Schambelan M, Lindenfeld S, Morris RC Jr. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. N Engl J Med 1977;297:576-83
